Related Experiment Video
Updated: Aug 10, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Detection of antigen specific circulating immune complexes in Indian kala-azar
1National Institute of Communicable Diseases, Delhi, India.
Insights
Active kala-azar cases show elevated circulating immune complexes (CIC). Antigen-specific CIC detection may aid in monitoring treatment effectiveness and patient recovery from this parasitic disease.
Area of Science:
- Immunology
- Parasitology
- Tropical Medicine
Background:
- Kala-azar, a severe form of leishmaniasis, is characterized by parasitic infection.
- Circulating immune complexes (CIC) are implicated in the pathogenesis of various infectious diseases.
Purpose of the Study:
- To investigate the presence and levels of antigen-specific CIC in patients with kala-azar.
- To evaluate the utility of CIC detection for monitoring therapeutic response and recovery.
Main Methods:
- Sera from active, clinically diagnosed, and treated kala-azar patients were analyzed.
- Antigen-specific enzyme-linked immunosorbent assay (ELISA) was employed to detect CIC.
Main Results:
- 100% of proved kala-azar cases exhibited elevated CIC levels.
- CIC positivity was observed in 64.3% of clinically diagnosed and 58.8% of treated cases.
- A significant decrease in CIC levels was noted post-treatment.
Conclusions:
- Antigen-specific CIC are prevalent in active kala-azar.
- Monitoring CIC levels can be a valuable tool for assessing treatment efficacy and patient recovery in kala-azar.
- This diagnostic approach may improve kala-azar management strategies.
Abstract:
The sera of active and treated cases of kala-azar were tested for circulating immune complexes (CIC) by antigen-specific enzyme linked immunosorbent assay (ELISA). All (100%) of proved cases had elevated CIC; 64.3% of clinically diagnosed cases and 58.8% of treated cases were also positive for CIC. A fall in the level of CIC was observed after treatment. Detection of antigen-specific CIC may be useful in monitoring the therapeutic effect and recovery.

